Caricamento...
Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models
BACKGROUND: HER2 is an oncogene, expression of which leads to poor prognosis in 30% of breast cancer patients. Although trastuzumab is apparently an effective therapy against HER2-positive tumors, its systemic toxicity and resistance in the majority of patients restricts its applicability. In this s...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3412708/ https://ncbi.nlm.nih.gov/pubmed/22824293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-10-80 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|